These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 8879614

  • 1. Bone marrow transplantation for the treatment of haematological disorders in Down's syndrome: toxicity and outcome.
    Rubin CM, Mick R, Johnson FL.
    Bone Marrow Transplant; 1996 Sep; 18(3):533-40. PubMed ID: 8879614
    [Abstract] [Full Text] [Related]

  • 2. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
    Bostrom B, Weisdorf DJ, Kim T, Kersey JH, Ramsay NK.
    Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
    [Abstract] [Full Text] [Related]

  • 3. Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing conditioning regimens.
    Woods WG, Ramsay NK, Weisdorf DJ, Haake R, Vallera DA, Kim TH, Lasky L, Nesbit ME, Bostrom B, Uckun F.
    Bone Marrow Transplant; 1990 Jul; 6(1):9-16. PubMed ID: 2202462
    [Abstract] [Full Text] [Related]

  • 4. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
    Wu DP, Milpied N, Moreau P, Mechinaud-Lacroix F, Mahe B, Le Tortorec S, Rapp MJ, Bourdin S, Mahe JM, Harousseau JL.
    Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF.
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C, Aversa F, Raymondi C, Marsella AR, Panizza BM, Perrucci E, Piro F, Maranzano E, Lupattelli M, Martelli MF, Latini P.
    Cancer J Sci Am; 1996 Jul; 2(6):330-4. PubMed ID: 9166553
    [Abstract] [Full Text] [Related]

  • 7. A preparatory regimen of total body irradiation, busulphan and melphalan for allogeneic bone marrow transplantation in childhood high-risk leukemia and lymphoma.
    Yoshihara T, Naya M, Tsunamoto K, Hojo M, Hibi S, Morimoto A, Todo S, Imashuku S.
    Anticancer Res; 2003 Jul; 23(2C):1739-42. PubMed ID: 12820450
    [Abstract] [Full Text] [Related]

  • 8. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    Socié G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, Cahn JY, Passweg JR, Rowlings PA, Schouten HC, Kolb HJ, Klein JP.
    N Engl J Med; 1999 Jul 01; 341(1):14-21. PubMed ID: 10387937
    [Abstract] [Full Text] [Related]

  • 9. [Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center].
    Schmitz N, Kayser W, Gassmann W, Euler HH, Wüstemann M, Brix F, Dühmke E, Hebbinghaus D, Gremmel H, Schaub J.
    Dtsch Med Wochenschr; 1985 Sep 27; 110(39):1488-93. PubMed ID: 3896727
    [Abstract] [Full Text] [Related]

  • 10. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.
    Haematologica; 2002 Jan 27; 87(1):52-8. PubMed ID: 11801465
    [Abstract] [Full Text] [Related]

  • 11. [Allogeneic hematopoietic transplantation with stem cells extracted from peripheral blood].
    Kusminsky G, Foncuberta MC, Aversa L, Drelichman G, Freigeiro D, Burgos R, Irrazabal C, Gonzalez G, Dictar M, Niborski R, Kohan A, Sanchez Avalos JC.
    Medicina (B Aires); 2000 Jan 27; 60(2):179-87. PubMed ID: 10962806
    [Abstract] [Full Text] [Related]

  • 12. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
    Kröger N, Zabelina T, Sonnenberg S, Krüger W, Renges H, Stute N, Finkenstein F, Mayer U, Holstein K, Fiedler W, Colberg H, Sonnen R, Kuse R, Braumann D, Metzner B, del Valle F, Erttmann R, Kabisch H, Zander AR.
    Bone Marrow Transplant; 2000 Oct 27; 26(7):711-6. PubMed ID: 11042650
    [Abstract] [Full Text] [Related]

  • 13. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up.
    Oyekunle AA, Kröger N, Zabelina T, Ayuk F, Schieder H, Renges H, Fehse N, Waschke O, Fehse B, Kabisch H, Zander AR.
    Bone Marrow Transplant; 2006 Jan 27; 37(1):45-50. PubMed ID: 16258531
    [Abstract] [Full Text] [Related]

  • 14. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
    Carlens S, Ringdén O, Aschan J, Hägglund H, Ljungman P, Mattsson J, Remberger M.
    Clin Transplant; 1998 Apr 27; 12(2):84-92. PubMed ID: 9575394
    [Abstract] [Full Text] [Related]

  • 15. High-dose cytosine arabinoside and fractionated total body irradiation as a preparative regimen for the treatment of children with acute lymphoblastic leukemia and Down syndrome by allogeneic bone marrow transplantation.
    Conter V, D'Angelo P, Rizzari C, Jankovic M, Dampier C, Masera G, Johnson FL.
    Bone Marrow Transplant; 1996 Feb 27; 17(2):287-9. PubMed ID: 8640182
    [Abstract] [Full Text] [Related]

  • 16. Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis.
    Atkinson K, Biggs J, Noble G, Ashby M, Concannon A, Dodds A.
    Bone Marrow Transplant; 1987 Dec 27; 2(4):385-94. PubMed ID: 3332186
    [Abstract] [Full Text] [Related]

  • 17. Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies.
    Small TN, Young JW, Castro-Malaspina H, Prockop S, Wilton A, Heller G, Boulad F, Chiu M, Hsu K, Jakubowski A, Kernan NA, Perales MA, O'Reilly RJ, Papadopoulos EB.
    Biol Blood Marrow Transplant; 2007 Feb 27; 13(2):235-44. PubMed ID: 17241929
    [Abstract] [Full Text] [Related]

  • 18. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients.
    Katsanis E, Shapiro RS, Robison LL, Haake RJ, Kim T, Pescovitz OH, Ramsay NK.
    Bone Marrow Transplant; 1990 May 27; 5(5):335-40. PubMed ID: 2350628
    [Abstract] [Full Text] [Related]

  • 19. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
    Belkacémi Y, Ozsahin M, Rio B, Laporte JP, Leblond V, Pène F, Laugier A.
    Strahlenther Onkol; 1995 Dec 27; 171(12):694-7. PubMed ID: 8545791
    [Abstract] [Full Text] [Related]

  • 20. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
    Matsuyama T, Kojima S, Kato K.
    Bone Marrow Transplant; 1998 Jul 27; 22(1):21-6. PubMed ID: 9678791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.